Wordt geladen...
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
Tyrosine kinases present attractive drug targets for specific types of cancers. Gleevec, a well-known therapeutic agent against chronic myelogenous leukemia, is an effective inhibitor of Abl tyrosine kinase. However, Gleevec fails to inhibit closely homologous tyrosine kinases, such as c-Src. Becaus...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
National Academy of Sciences
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3562763/ https://ncbi.nlm.nih.gov/pubmed/23319661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1214330110 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|